Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SmartCentres Real Estate Investment Trust T.SRU.UN

Alternate Symbol(s):  CWYUF

SmartCentres Real Estate Investment Trust (the Trust) is a Canada-based fully integrated real estate investment trust. The Trust develops, leases, constructs, owns and manages shopping centers, office buildings, high-rise and low-rise condominiums and rental residences, seniors’ housing, townhome units, self-storage rental facilities, and industrial facilities in Canada. It is focused on development, ownership, management and operation of investment properties located in Canada. The Trust portfolio features approximately 191 strategically located properties in communities across the country. The Trust’s subsidiaries include Smart Limited Partnership, Smart Limited Partnership II, Smart Limited Partnership III, Smart Limited Partnership IV, Smart Oshawa South Limited Partnership, Smart Oshawa Taunton Limited Partnership, Smart Boxgrove Limited Partnership, ONR Limited Partnership, ONR Limited Partnership I, and SmartVMC West Limited Partnership.


TSX:SRU.UN - Post by User

Comment by 13thon Feb 13, 2008 4:58am
316 Views
Post# 14364078

RE: MASSIVE NEWS. THANKS

RE: MASSIVE NEWS. THANKSPhotobucket"""-----INNEXUS BIOTECHNOLOGY INC ( IXS.V )-----"""size=4>color=RED> MAJOR NEWS----InNexus says study shows DXL625 kills tumour cellssize=4> INNEXUS BIOTECHNOLOGY ( TRADING JUST AT 0.35 CENTS ) ANNOUNCES PRELIMINARY RESULTS OF ANIMAL STUDY COMPARING CANCER KILLING ACTIVITY OF ITS DXL625 (CD20) TREATMENT FOR NON-HODGKIN'S LYMPHOMA WITH LEADING MARKETED PRODUCT UP 200% AND RISING FAST,,HEDGE FUNDS ARE BUYING LARGEsize=4>color=RED> https://stockcharts.com/h-sc/ui?s=ixs.V&p=D&b=5&g=0&id=p95524307080 -PENDING NEWS OF 30 MILLION ROYALTY @ PRICE OF $ 1.01 GANA MAKE THIS STOCK FLY -DXL 625 is IXS's first drug offering that enhances or betters Rituxan a $2.06 Billion a year drug. -The animal testing results show that DXL 625 is more effective than Rituxan (remember a $2 Billion drug). -The CEO has indicated a 2nd drug is in the works and another $30 Million from Royalty will be soon be available to company @ price of $ 1.01 per share Show me another Biotech with this much going for it with such a low market cap. This thing is going to take off.------------- Recommandation *STRONG BUY* --------------size=4> THIS STOCK IS AT THE TOP OF THE PHARMACEUTICAL WORLD - PLACE YOUR BETS BUY LOW BEFORE HEADING TO DA MOOOOOOOOOON
Bullboard Posts